Decreasing case fatality in myocardial infarction is explained by improved medical treatment

References

• World Health Organization Statistical Information System. www.who.int/whosis/ 2009.
   Google Scholar
• Morbidity and mortality. 2009 chart book on cardiovascular, lung and blood diseases. Bethesda, MD, National Heart, Lung and Blood Institute, 2009. www.nhIbi.nih.gov/resources/docs/cht-book.htm.
   Google Scholar
• Writing Group Members, Lloyd-Jones D, Adams RI, Brown TM, Carnethon M, Dai 5, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern 5, Ho PM, Howard V, Kissela B, Kittner 5, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P. Stafford R, Thom T, Wasserthiel-Smoller 5, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010; 121: e46–e215.
   Google Scholar
• Abrahamsson P. Dellborg M, Rosengren A, Wilhelmsen L. Improved long-term prognosis after myocardial infarction 1984-1991. Eur HeartJ 1998; 19:1512–7.
   Google Scholar
• Furman M, Dauerman H, Goldberg R, Yarzebski J, Lessard D, Gore J. Twenty-two year (1975-1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Qwave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001; 37:1571–80.
   Google Scholar
• The ISIS-2 collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2(8607): 349–60.
   Google Scholar
• GISSI. Long-term effects of intravenous thrombolysis in acute myocardialinfarction: final report of the GISSI study. Lancet 1987; 2(8564): 871–4.
   Google Scholar
• Becker R.The emergence of thrombocardiol-ogy. J Thromb Thrombolysis 1994; 1:41–3.
   Google Scholar
• The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673–82.
   Google Scholar
• The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337:1118–23.
   Google Scholar
• Van de Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P. Barbash G, Betriu A, Binbrek AS, Califf R, Diaz R, Fanebust R, Fox K, Granger C, Heikkil6 J, Husted 5, Jansky P. Langer A, Lupi E, Maseri A, Meyer J, Mlczoch J, Mocceti D, Myburgh D, Oto A, Paolasso E, Pehrsson K, Seabra-Gomes R, Soares-Piegas L, Siligrue D, Tendera M, Topol E, Toutouzas P. Vahanian A, Verheugt F, Wallentin L, White H. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 1999; 354:716–22.
   Google Scholar
• Sabatine MS, Cannon CP, Gibson CM, López-SencIón JL, Montalescot G, Theroux P. Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005; 352:1179–89.
   Google Scholar
• Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366:1607–21.
   Google Scholar
• de Bono DP, Simoons ML, Tijssen J, Arnold AE, Betriu A, Burgersdijk C, Lopez Bescos L, Mueller E, Pfisterer M, Van de Werf F, Zijlstra F, Verstraete M. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Br HeartJ 1992; 67: 122–8.
   Google Scholar
• 45 Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (45). Lancet 1994; 344:1383-9.
   Google Scholar
• Schwartz G, Olsson A, Ezekowitz M, Ganz P. Oliver M, Waters D, Zeiher A, Chaitman B, Leslie 5, Stern T. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACLE study: a randomized controlled trial. JAMA 2001; 285:1711–8.
   Google Scholar
• Ray K, Cannon C, McCabe C, Cairns R, Tonkin A, Sacks F, Jackson G, Braunwald E. Early and late benefit of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005; 46: 1405–10.
   Google Scholar
• Zijlstra F, De Boer M, Hoorntje J, Reiffers 5, ReiberJ, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328:680–4.
   Google Scholar
• Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J, Overlie P. Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki 5, O’Neill WW. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673–9.
   Google Scholar
• Sabatine MS, Cannon CP, Gibson CM, López-SencIón JL, Montalescot G, Theroux P. Lewis BS, Murphy SA, McCabe CH, Braunwald E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 2005; 294: 1224–32.
   Google Scholar
• Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna 0, Eijgelshoven M, Lansky AJ, O’Neill WW, Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949–56.
   Google Scholar
• The Global Use of Strategies to open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO 11b) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336:1621–8.
   Google Scholar
• Widimsky P. Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicenter randomized trial comparing transport to primary angioplasty versus immediate thrombolysis versus combined strategy for patients with acute myocardial infarction presenting to a community hospital without catheterization laboratory (the PRAGUE Study). Eur Heart J 2000; 21:823–31.
   Google Scholar
• Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P.Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P. Husted SE, Vigholt E, Kjaergard HK, Mortensen LS, DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733–42.
   Google Scholar
• The MIAMI trial research group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 1985; 6: 199–211.
   Google Scholar
• Freemantle N, Cleland J, Young P. Mason J, Harrison J. Beta blockade after myocardial infarction:systematic review and meta regression analysis. BMJ 1999; 318:1730–7.
   Google Scholar
• GISSI-3. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italian° per lo Studio della Sopravvivenza nell’infarto Miocardico. Lancet 1994; 343:1115–22.
   Google Scholar
• ISIS-4. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995; 345: 669–85.
   Google Scholar
• Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin 0, Gabriel 5, Jackson J, Chen R, Caro J, Steinhubl 5, Topal E, Weintraub WS. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronaryintervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. J Am Coll Cardiol 2005; 46: 761–9.
   Google Scholar
• Kristjansson JM, Andersen K. Improved one-year survival after acute myocardial infarction in Iceland between 1986 and 1996. Cardiology 1999; 91:210–4.
   Google Scholar
• Sigfusson N, Sigurdsson G, Agnarsson U, Gudmundsdottir II, Stefansdottir I, Sigvaldason H, Gudnason V. Declining coronary heart disease mortality in Iceland: contribution by incidence, recurrence and case fatality rate. Scand Cardiovasc J 2002; 36: 337–41.
   Google Scholar
• Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, Meisinger C. 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985-2004). J Intern Med 2008; 264: 254–64.
   Google Scholar
• Sigfusson N, Sigvaldason H, SteingrimsdottirL, Gudmundsdottir II, Stefansdottir ITT, Sigurdsson G. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ 1991; 302:1371–5.
   Google Scholar
• Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;41: 155–78.
   Google Scholar
• MacIntyre K, Stewart 5, Capewell S, Chalmers JW, Pell JP, Boyd J, Finlayson A, Redpath A, Gilmour H, McMurray JJ. Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001; 38:729–35.
   Google Scholar
• Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217–25.
   Google Scholar
• Kanamasa K, Ishikawa K, Hayashi T, Hoshida 5, Yamada Y, Kawarabayashi T, Naka M, YokoiY, Matsuda M, Ogawa I. Increased cardiac mortality in women compared with men in patients with acute myocardial infarction. Intern Med 2004; 43:911–8.
   Google Scholar